NCT02886286View on ClinicalTrials.gov

Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Pain, IntractableBreakthrough PainChronic Pain
Interventions
DRUG

Bupivacaine

Patient-activated intrathecal bolus for incident pain

DRUG

Opioid

Patient-activated intrathecal bolus for incident pain

Trial Locations (1)

44106

University Hospitals Case Medical Center, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER

NCT02886286 - Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain | Biotech Hunter | Biotech Hunter